Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial

Journal of Clinical Oncology - United States
doi 10.1200/jco.2014.57.6926
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Osteoporosis Therapy and Outcomes for Postmenopausal Patients With Hormone Receptor-Positive Breast Cancer: NCIC CTG MA.27

Cancer
Cancer ResearchOncology
2017English

Aromatase Inhibitor Associated Musculoskeletal Symptoms Are Associated With Reduced Physical Activity Among Breast Cancer Survivors

Breast Journal
Internal MedicineSurgeryOncology
2013English

Complementary and Alternative Medicine and Musculoskeletal Pain in the First Year of Adjuvant Aromatase Inhibitor Treatment in Early Breast Cancer Patients

Breast
MedicineCancer ResearchOncologySurgery
2020English

Randomized, Blinded Trial of Vitamin D3 for Treating Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS)

Breast Cancer Research and Treatment
Cancer ResearchOncology
2016English

The Analysis of Relapse-Free Survival Curves: Implications for Evaluating Intensive Systemic Adjuvant Treatment Regimens for Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2005English

The Effect of Exercise on Aromatase Inhibitor-Induced Musculoskeletal Symptoms in Breast Cancer Survivors :A Systematic Review and Meta-Analysis

Supportive Care in Cancer
Oncology
2019English

Improved Relapse-Free Survival on Aromatase Inhibitors in Breast Cancer Is Associated With Interaction Between Oestrogen Receptor-Α and Progesterone Receptor-B

British Journal of Cancer
Cancer ResearchOncology
2018English

Octreotide LAR and Tamoxifen Versus Tamoxifen in Phase III Randomize Early Breast Cancer Trials: NCIC CTG MA.14 and NSABP B-29

Breast Cancer Research and Treatment
Cancer ResearchOncology
2015English

Autoimmune Hepatitis Deteriorated by Anastrozole, an Aromatase Inhibitor, for Breast Cancer Adjuvant Chemotherapy

Acta Hepatologica Japonica
Hepatology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy